
Panstar 40 Injection
Marketer
Leo Star Healthcare Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Panstar 40 Injection
Gastric acid secretion is suppressed by the intravenous medication, AcidBloc 40 Injection. Indicated for managing stomach and intestinal disorders stemming from excess acid, including gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome, it alleviates symptoms and aids healing. Prophylactically, AcidBloc 40 Injection prevents stress ulcers in critically ill patients and is administered pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this injection is solely administered intravenously by a healthcare professional when deemed clinically preferable to oral forms. Dosage and treatment length are determined by your physician based on individual needs and response. Consistent adherence to the prescribed regimen is crucial, even with rapid symptom resolution. Dietary modifications, such as smaller, more frequent meals, and avoidance of caffeine, spicy, and fatty foods, can enhance treatment efficacy. Common, generally mild, adverse reactions may include nausea, vomiting, headache, vertigo, flatulence, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical consultation. Prolonged use, particularly exceeding one year, may elevate the fracture risk, especially at higher doses. Discuss bone health maintenance, including calcium and vitamin D supplementation, with your doctor. AcidBloc 40 Injection is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or pre-existing osteoporosis. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption, exacerbating acid production, should be avoided. Refrain from operating machinery if drowsiness or dizziness occurs.
Primary Ingredients of Panstar 40 Injection
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Panstar 40 Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Panstar 40 Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Panstar 40 Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Panstar 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Panstar 40 Injection works:
Acid reflux and heartburn find relief with Panstar 40 Injection, a proton pump inhibitor (PPI) that lessens stomach acid production.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Panstar 40 Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Panstar 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and Panstar 40 Injection appear compatible. Available human data indicate minimal infant risk associated with maternal use.
DrivingCONSULT YOUR DOCTOR
Panstar 40 Injection's impact on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Panstar 40 Injection presents no contraindications for use in patients with renal impairment; dose modification is unnecessary.
LiverCAUTION
Patients with significant hepatic impairment should use Panstar 40 Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Panstar 40 Injection :
Omit a scheduled Panstar 40 Injection? Seek your physician's advice.
Facts to Know About Panstar 40 Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
| Behavior Class | Gastric acid suppressants |
